Skip to content

A pilot randomised controlled trial of occupational therapy to optimise recovery for patients undergoing primary total hip replacement for osteoarthritis

A pilot randomised controlled trial of occupational therapy to optimise recovery for patients undergoing primary total hip replacement for osteoarthritis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN38381590
Enrollment
60
Registered
2012-02-06
Start date
2012-02-01
Completion date
Unknown
Last updated
2016-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Musculoskeletal, All Diseases Musculoskeletal Diseases Other disorders of the musculoskeletal system

Interventions

A multi centre pilot RCT of a pre-surgery home based occupational intervention versus hospital based usual care. Sixty participants awaiting primary elective unilateral total hip replacement (THR) due

Sponsors

University of Birmingham (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients accepted for surgery for primary THR following review in orthopaedic clinic 2. No previous lower limb joint replacement surgery 3. Osteoarthritis as the primary indication for surgery 4. No planned additional lower limb joint replacement surgery within 12 months 5. Unilateral surgery 6. Male & female participants 7. Lower Age Limit 55 years

Exclusion criteria

Exclusion criteria: 1. Patients with inflammatory arthritis 2. Patients whose existing comorbidities prevent them from participating in the proposed treatment intervention (such as stroke or amputation) 3. Patients who are unable to provide informed consent

Design outcomes

Primary

MeasureTime frame
Assess the feasibility of a full scale RCT measured at the end of study with respect to: 1. Recruitment procedures measured by identification and response rates, recruitment rates and establishment of site specific procedures 2. Appropriateness, responsiveness and acceptability of outcome measures measured by analysis of any missing data and completion rates 3. Fidelity of the intervention assessed by dropout rates, content of the intervention using an intervention log and acceptability of randomisation into the intervention/control.

Secondary

MeasureTime frame
1. Pain 2. Functional activity 3. Societal participation Measured at 4, 12 and 26 weeks and physical activity levels at 12 weeks (using accelerometry). 4. Record resource use 5. Adverse events 6. Clinical effect size 7. Directionality of the outcome measure questionnaires Measured at the end of study 8. Health resource usage measured at 26 weeks 9. Pain 10. Functional activity 11. Societal participation The above outcomes will be measured using patient administered questionaires at 4, 12 and 26 weeks 12. Physical activity using accelerometery will be measured at 12 weeks

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026